Sartorius Stedim stock climbs on a 21.41% analyst gap

Sartorius Stedim stock trades at EUR 194.80 with a 21.41% gap to the 38-analyst average target of EUR 236.50. The company also sits 14.11% below its 52-week high as biotech demand signals stay in view.

Sartorius Stedim Biotech S.A. (FR0013154002) trades at EUR 194.80, and that puts the stock 21.41% below the 38-analyst average target of EUR 236.50 as of August 25, 2026.

The same market snapshot shows a 24-hour gain of 2.04%, a 7-day move of 6.26%, and a 30-day advance of 14.23%, while the shares still sit 14.11% under their 52-week high.

Valuation gap stays visible

The average target is one concrete reference point, but the more useful comparison for investors is the gap between EUR 194.80 and EUR 236.50. That spread leaves the stock with room to rerate if operating momentum holds.

MarketScreener also shows Sartorius AG at EUR 244.25 in real time, down 0.04% on the session and up 3.69% over five days, with a 1st Jan change of -1.31% as of August 25, 2026.

Biotech context matters

Wallstreet Online describes Sartorius Stedim as a supplier of instruments and consumables for biopharma production, spanning cell culture media, bioreactors, separation and purification tools, and software for process optimization.

That product mix matters because it ties the company to recurring demand from drug makers and research labs, not just one-off equipment sales.

Representative product line

One representative product area is single-use bioprocessing hardware and consumables, where Sartorius Stedim sells systems used in cultivation, fermentation, separation, and fluid management.

For investors, the current setup is simple: the shares are above both the 7-day and 30-day moves, but still below the 52-week peak and below the analyst average target.

Stock levels and timing

As of August 25, 2026, the stock change, the 52-week gap, and the analyst target gap give the clearest near-term framework for the name.

Price: EUR 194.80 as of August 25, 2026, 5:38 p.m. local time.

Fact box

Company: Sartorius Stedim Biotech S.A.

ISIN: FR0013154002

Ticker: DIM

Exchange: France

Price (as of August 25, 2026, 5:38 p.m. local time): EUR 194.80

Market cap: EUR 18.96 billion

Sector / Industry: Biotechnology

Index membership: not stated in the cited sources

Investor Relations

More on Sartorius Stedim stock.

View Sartorius Stedim Biotech on the company investor-relations page.